XML 144 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Certain Transactions - Other Transactions - Additional Information (Detail)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 08, 2018
USD ($)
May 12, 2017
USD ($)
Mar. 03, 2016
USD ($)
Sep. 30, 2018
USD ($)
Dec. 31, 2016
USD ($)
Nov. 30, 2016
USD ($)
Sep. 30, 2016
USD ($)
Lawsuit
Dec. 31, 2018
USD ($)
Mar. 31, 2018
USD ($)
Jun. 30, 2017
USD ($)
Sep. 30, 2016
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Oct. 31, 2016
USD ($)
Noncash or Part Noncash Acquisitions [Line Items]                              
Other asset impairments, restructuring and other items                       $ 423.0 $ 987.0 $ 1,836.0  
Net (gain) loss from sale of long-lived assets and investments                       $ (18.0) $ (19.0) (1,090.0)  
PGT Healthcare Partnership [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Other asset impairments, restructuring and other items                 $ 64.0            
Write-down of investment                 94.0            
Net (gain) loss from sale of long-lived assets and investments       $ 50.0                      
Rimsa [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Cash consideration     $ 2.3                        
Number of lawsuits filed | Lawsuit             2                
Alder [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Upfront payment $ 25.0                            
Collaborative agreement milestone payments $ 175.0                            
Otsuka [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Upfront payment   $ 50.0                          
Attenukine [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Upfront payment         $ 30.0                    
Milestone payment                           $ 20.0  
Additional considerations         $ 260.0                    
Ninlaro [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Upfront payment           $ 150.0                  
Payment           150.0                  
Upfornt payments received           $ 150.0                  
Celltrion [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Refundable payment                             $ 60.0
Total associated cost                             $ 160.0
Regeneron [Member]                              
Noncash or Part Noncash Acquisitions [Line Items]                              
Upfront payment                     $ 250.0        
Collaborative agreement milestone payments               $ 60.0 $ 35.0 $ 25.0          
Research and development costs             $ 1,000.0